04:34 PM EDT, 08/07/2025 (MT Newswires) -- Gilead Sciences ( GILD ) reported fiscal Q2 adjusted earnings late Thursday of $2.01 per diluted share, unchanged from a year earlier.

Analysts polled by FactSet expected $1.96.

Revenue for the quarter ended June 30 was $7.08 billion, up from $6.95 billion a year earlier.

Analysts surveyed by FactSet expected $6.98 billion.

The company adjusted its full-year 2025 EPS guidance to $7.95 to $8.25 from $7.70 to $8.10 previously. Analysts expect $8.02.

The company now expects 2025 revenue of $28.30 billion to $28.70 billion from $28.20 billion to $28.60 billion earlier. Analysts expect $28.78 billion.

The company maintained its quarterly dividend at $0.79 per share, payable Sept. 29 to holders of record Sept. 15.

The company also authorized a new $6 billion stock buyback.